HeartBeam Inc. has announced a strategic collaboration with HeartNexus that will expand access to cardiologist-level ECG insights for arrhythmia assessment. The partnership makes board-certified cardiologists available 24/7 to interpret results from HeartBeam's portable ECG system and provide expert feedback directly to patients or coordinating clinicians. Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths annually according to the World Health Organization. This collaboration addresses a critical gap in cardiac care by enabling remote ECG monitoring and interpretation, potentially improving early detection of arrhythmias and other cardiac conditions.
The HeartBeam System allows patients to capture 30-second ECG recordings using a credit-card-sized, cable-free device that can be used anywhere. The portable non-invasive recorder is intended to record, store, and transfer a patient's 3-Lead electrocardiogram acquired from 5 electrodes. The device is designed for use by adult patients in either clinical settings or at home, though it does not conduct cardiac analysis itself. For full safety information, healthcare professionals can reference the complete Instructions for Use or Clinician Portal Manual available through the company's resources. The system works with ECG Viewer software for manual interpretation of non-life-threatening arrhythmias by physicians or healthcare professionals.
This partnership represents a significant advancement in remote cardiac monitoring technology, particularly given that standard ECG testing often requires in-clinic visits and specialized equipment. The ability to access cardiologist interpretation remotely could transform how cardiac conditions are monitored and managed, especially for patients in remote areas or those with mobility limitations. The collaboration between HeartBeam and HeartNexus comes at a time when cardiovascular disease continues to pose a major global health challenge. By combining portable ECG technology with immediate access to cardiologist expertise, the partnership aims to provide more timely cardiac assessments and potentially improve patient outcomes through earlier detection and intervention.
